Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Short Interest Update

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 2,800 shares, an increase of 250.0% from the February 28th total of 800 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 531,600 shares, the short-interest ratio is currently 0.0 days.

Daiichi Sankyo Stock Down 1.9 %

Shares of OTCMKTS:DSNKY traded down $0.48 during trading hours on Thursday, hitting $24.57. The company’s stock had a trading volume of 116,945 shares, compared to its average volume of 245,706. The firm’s fifty day moving average price is $24.99 and its 200 day moving average price is $29.02. Daiichi Sankyo has a 52 week low of $22.47 and a 52 week high of $42.48. The company has a market capitalization of $46.89 billion and a price-to-earnings ratio of 28.57. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.77 and a quick ratio of 2.11.

Daiichi Sankyo (OTCMKTS:DSNKY) last posted its earnings results on Friday, January 31st. The company reported $0.22 earnings per share for the quarter. Daiichi Sankyo had a return on equity of 14.53% and a net margin of 13.62%. As a group, research analysts expect that Daiichi Sankyo will post 0.73 EPS for the current year.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.